Skip to Content

Sunlenca 300 mg film-coated tablets

Licence status
Authorised: 17/08/2022
Active substances
Lenacapavir sodium
Dosage Form
Film-coated tablet
Licence number
EU/1/22/1671/01
Licence holder
Gilead Sciences Ireland UC

Licence information

ATC code
J05AX Other antivirals, J05AX31 Lenacapavir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
17/08/2022